Target intelligence / Profile preview

Aspartate-rich protein 1 (DRICH1)

Target
DRICH1
Molecular classification
Other
01

Overview

Aspartate-rich protein 1 (DRICH1) is a protein-coding gene in humans, also referred to as C22orf43 or KB-208E9.1[3][9]. It encodes a protein with a high content of aspartate residues. The molecular function of DRICH1 is not well characterized; current evidence suggests only general protein binding activity (GO:0005515)[1][5]. There is no established evidence that DRICH1 functions as a classic therapeutic target such as a receptor, enzyme, transporter, or transcription factor, nor is there evidence implicating direct involvement in specific molecular pathways or drug interactions. DRICH1 is associated with certain disease states based on genetic studies, including childhood acute lymphocytic leukemia and distal chromosome 22q11.2 deletion syndrome[3]. However, there is no current evidence for its use as a biomarker or safety concerns related to modulation.

Other names
Aspartate-rich protein 1DRICH1C22orf43KB-208E9.1aspartate rich 1
02

Biological functions

Protein binding
03

Disease associations

Childhood acute lymphocytic leukemiaChromosome 22q11.2 deletion syndrome, distal

Beyond the preview

Go deeper on Aspartate-rich protein 1 (DRICH1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aspartate-rich protein 1 (DRICH1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call